Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome 26S subunit, ATPase 1 pseudogene 11 (*PSMC1P11*) is classified as a pseudogene and thus does not encode a functional protein; it is related by sequence to the gene encoding proteasome 26S subunit, ATPase 1 (*PSMC1*), but there is no evidence that *PSMC1P11* is transcribed into a functional protein or acts as a molecular target[5]. Pseudogenes such as *PSMC1P11* often arise from gene duplication events but have lost their protein-coding ability through mutation and typically do not have a direct role in cellular biology, disease, or as drug targets[5]. Any information about molecular function, drug interaction, or disease relevance refers to the parent gene *PSMC1* and not to *PSMC1P11*[2][3][5].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit, ATPase 1 pseudogene 11 (PSMC1P11).